Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury

Massimo Collino, Mara Rogazzo, Alessandro Pini, Elisa Benetti, Arianna Carolina Rosa, Fausto Chiazza, Roberto Fantozzi, Daniele Bani, Emanuela Masini

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Although recent preclinical and clinical studies have demonstrated that recombinant human relaxin (rhRLX) may have important therapeutic potential in acute heart failure and chronic kidney diseases, the effects of acute rhRLX administration against renal ischaemia/reperfusion (I/R) injury have never been investigated. Using a rat model of 1-hr bilateral renal artery occlusion followed by 6-hr reperfusion, we investigated the effects of rhRLX (5 μg/Kg i.v.) given both at the beginning and after 3 hrs of reperfusion. Acute rhRLX administration attenuated the functional renal injury (increase in serum urea and creatinine), glomerular dysfunction (decrease in creatinine clearance) and tubular dysfunction (increase in urinary excretion of N-acetyl-β-glucosaminidase) evoked by renal I/R. These beneficial effects were accompanied by a significant reduction in local lipid peroxidation, free radical-induced DNA damage and increase in the expression/activity of the endogenous antioxidant enzymes Mn- and CuZn-superoxide dismutases (SOD). Furthermore, rhRLX administration attenuated the increase in leucocyte activation, as suggested by inhibition of myeloperoxidase activity, intercellular-adhesion-molecule-1 expression, interleukin (IL)-1β, IL-18 and tumour necrosis factor-α production as well as increase in IL-10 production. Interestingly, the reduced oxidative stress status and neutrophil activation here reported were associated with rhRLX-induced activation of endothelial nitric oxide synthase and up-regulation of inducible nitric oxide synthase, possibly secondary to activation of Akt and the extracellular signal-regulated protein kinase (ERK) 1/2, respectively. Thus, we report herein that rhRLX protects the kidney against I/R injury by a mechanism that involves changes in nitric oxide signalling pathway.

Lingua originaleInglese
pagine (da-a)1494-1505
Numero di pagine12
RivistaJournal of Cellular and Molecular Medicine
Volume17
Numero di pubblicazione11
DOI
Stato di pubblicazionePubblicato - nov 2013
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury'. Insieme formano una fingerprint unica.

Cita questo